GMI Interventional Cardiology & Peripheral Vascular De | Page 2

Browse key industry insights from the report “Interventional Cardiology &
Peripheral Vascular Devices Market Size, Industry Analysis Report, Regional
Outlook (U.S., Canada, Germany, UK, Italy, France, Spain, Poland, China, India,
Japan, Australia, Malaysia, Indonesia, Thailand, South Korea, Brazil, Mexico,
Argentina, South Africa, Saudi Arabia, UAE), Application Development Potential,
Price Trends, Competitive Market Share & Forecast, 2017 – 2024” in detail along
with the table of contents:
https://www.gminsights.com/industry-analysis/interventional-cardiology-and-
peripheral-vascular-devices-market
Hospitals segment will witness for major revenue share due to availability of advanced
technologies for disease treatment. Furthermore, availability of skilled professional
coupled with low cost associated with treatment in hospital will boost the business
size.
U.S. will witness significant growth over the forecast period due to presence of strong
industry players like Abbott, C. R. brad and B. Braun offering quality products and
availability of large patient base. As per American Heart Association and American
Stroke Association 2017 statistics, cardiovascular disease, is recorded as the underlying
cause of death, which accounts for approximately 801,000 deaths in the U.S. and about
92.1 million adults are living with different form of cardiovascular disease in the
country.
UK will show lucrative growth over the forecast period. Rising prevalence of chronic
disorders coupled with adoption of novel technologies will fuel the revenue share.
Germany interventional cardiology & peripheral vascular devices market will grow at
healthy rate due to growing awareness towards novel methods and mounting demand
for minimally invasive technologies.
China will grow at a robust rate in coming years pertaining to increased sedentary
lifestyle, growing prevalence of obesity and increasing healthcare expenditure.
Moreover, improving healthcare infrastructure and rising prevalence of diabetes,
coronary heart disease, hypertension, and heart diseases will create lucrative growth
opportunities in India.
Some of the industry players are Abbott Vascular Devices, Biosense Webster, Boston
Scientific, B. Braun, C.R. Bard, Cook Group, Cordis, Medtronic, St. Jude Medical and
Terumo. Companies are focusing on introduction of novel technologies, collaboration
and acquisition to enhance their business portfolio as main strategies. For instance, in
May 2017, Cordis introduced RAILWAY sheathless access system and two new
percutaneous transluminal coronary angioplasty balloon catheters under Kaneka brand
named as Ikazuchi Zero and Raiden3.
2 | Page